NASDAQ : DVAX

Dynavax Technologies Corporation

$15.5 USD

$0 (0.0%)

Volume
5.66M
Average Volume
3.16M
Market Capitalization
$1.82B
P/E Ratio
-40.79
Dividend Yield
0.00%
Price Target
$29.00
Year High
$15.73
Year Low
$9.20
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$7.62
Company Overview

NASDAQ

Ryan Spencer

Drug Manufacturers - Specialty & Generic

Healthcare

DVAX

405

US

USD

https://www.dynavax.com

510 848 5100

268158201

0001029142

Liquidity Metrics

0.54

7.62

6.94

1.50

0.00

Sales & Valuation

$277.25M

7.04

3.40

58.70

0.26

Profitability

$0.2

$27.31M

-19.52%

-18.66%

-9.71%

-5.33%

P/E Metrics

-40.79

0.08

0.08

Analyst Price Target & Rating

$29.00

$32.00

$20.00

N/A

0/5

11 Analysts

-46.55%

Poll Results

About Dynavax Technologies Corporation (NASDAQ:DVAX) Stock

Dynavax Technologies Corporation is a biopharmaceutical firm specializing in the development and market introduction of innovative vaccines, primarily operating in the United States. The company's lead product is HEPLISAV-B, a vaccine approved for adults 18 years and older in the U.S. and Europe, which offers protection against all identified subtypes of the hepatitis B virus. Additionally, Dynavax produces and distributes CpG 1018, the specific adjuvant ingredient used in HEPLISAV-B. Dynavax maintains several strategic alliances, including a collaboration agreement with Valneva Scotland Limited, an agreement with Serum Institute of India Pvt. Ltd., and a sublicense agreement with Merck, Sharp & Dohme Corp. The company, incorporated in 1996, was originally named Double Helix Corporation be ... fore adopting the name Dynavax Technologies Corporation in September of that year. Its corporate headquarters are situated in Emeryville, California.

Frequently Asked Questions

What is the current Dynavax Technologies Corporation (DVAX) stock price?

Dynavax Technologies Corporation(NASDAQ:DVAX) stock price is $15.5 in the last trading session. During the trading session, DVAX stock reached the peak price of $15.73 while $9.2 was the lowest point it dropped to. The percentage change in DVAX stock occurred in the recent session was 0.0% while the dollar amount for the price change in DVAX stock was $0.

DVAX's industry and sector of operation?

The NASDAQ listed DVAX is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.

Who are the executives of DVAX?

Ryan Spencer | Chief Executive Officer & Director
Kelly MacDonald | Senior Vice President & Chief Financial Officer
David F. Novack | Senior VP & COO
Joseph Metzinger | Vice President & Chief Accounting Officer
Paul Cox | Vice President of Investor Relations & Corporate Communications

How many employees does DVAX have?

Number of DVAX employees currently stands at 405. DVAX operates from 2100 Powell Street, EmeryVille, CA 94608, US.

Link for DVAX official website?

Official Website of DVAX is: https://www.dynavax.com

How do I contact DVAX?

DVAX could be contacted at phone #510 848 5100 and can also be accessed through its website. DVAX operates from 2100 Powell Street, EmeryVille, CA 94608, US.

How many shares of DVAX are traded daily?

The average number of DVAX shares traded daily for last 3 months was 3.16M.

What is the market cap of DVAX currently?

The market value of DVAX currently stands at $1.82B with its latest stock price at $15.5